XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Instruments and Fair Value Measurements (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Apr. 04, 2022
Sep. 30, 2022
Oct. 01, 2021
Sep. 30, 2022
Oct. 01, 2021
Dec. 31, 2021
Financial Instruments and Fair Value Measurements [Abstract]            
Long-term Debt, Fair Value   $ 400,000   $ 400,000   $ 2,100,000
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]            
Contingent consideration, liability   24,400   24,400    
Equity securities, fair value   200,274   200,274   0
Unrealized gain (loss) on investment in equity securities   (63,125) $ 0 72,412 $ 0  
Derivative asset, notional amount   2,800   2,800   7,600
ESAB Corporation            
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]            
Equity securities, fair value   200,300   200,300    
Unrealized gain (loss) on investment in equity securities   (63,100)   72,400    
ESAB Corporation            
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]            
Business separation, distribution to shareholders, ownership percentage after transaction 10.00%          
Foreign currency contracts related to customer sales contracts            
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]            
Unrealized losses on derivatives       200    
Realized losses   100   300    
Fair Value, Inputs, Level 3            
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]            
Contingent consideration, liability   29,400   29,400    
Fair Value, Inputs, Level 2            
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]            
Deferred compensation plans asset   $ 9,400   $ 9,400   $ 11,200